Vanessa Jacoby - 28 Jan 2026 Form 3 Insider Report for Sonoma Pharmaceuticals, Inc. (SNOA)

Role: Director
Signature: /s/ Amy Trombly as attorney-in-fact
Issuer symbol: SNOA
Transactions as of: 28 Jan 2026
Net transactions value: $0
Form type: 3
Filing time: 09 Feb 2026, 17:00:02 UTC
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Jacoby Vanessa	Director	C/O SONOMA PHARMACEUTICALS, INC., 5445 CONESTOGA COURT, SUITE 150, BOULDER	/s/ Amy Trombly as attorney-in-fact	09 Feb 2026	0002110126

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	SNOA	Stock option (right to buy)							28 Jan 2026	Common Stock	10,000	$10000.00	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Issuer granted the options as an initial grant due to Ms. Jacoby's appointment to the Board of Directors of the Issuer. The options vest in three equal tranches over a period of three years with the first tranche vesting on the first anniversary of the grant date, the second tranche vesting on the second anniversary of the grant date, and the third tranche vesting on the third anniversary of the grant date, or upon change in control.

Content

The Issuer granted the options as an initial grant due to Ms. Jacoby's appointment to the Board of Directors of the Issuer. The options vest in three equal tranches over a period of three years with the first tranche vesting on the first anniversary of the grant date, the second tranche vesting on the second anniversary of the grant date, and the third tranche vesting on the third anniversary of the grant date, or upon change in control.